DoW Peer Reviewed Cancer, Clinical Trial Award
This opportunity funds clinical trial projects under the FY26 Peer Reviewed Cancer Research Program, with the goal of improving how cancer is treated or managed. Trials can span from early-stage (phase 0/first-in-human) through larger efficacy studies up to phase III, and may test drugs or biologics, devices, clinical guidance, or emerging technologies. Applicants must include patient advocate…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
DoW Peer Reviewed Medical, Clinical Trial Award
Dept. of the Army -- USAMRAA
-
DoW, Peer Reviewed Cancer, Impact Award
Dept. of the Army -- USAMRAA
-
DoW Peer Reviewed Cancer, Idea Award
Dept. of the Army -- USAMRAA
-
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health ▸ National Cancer Institute
-
DoW Traumatic Brain Injury and Psychological Health, Clinical Trial Award
Dept. of the Army -- USAMRAA
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers